Yuri Izurieta: Debarment Order, 3776-3777 [2012-1489]
Download as PDF
3776
Federal Register / Vol. 77, No. 16 / Wednesday, January 25, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0592]
Yuri Izurieta: Debarment Order
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The U.S. Food and Drug
Administration (FDA) is issuing an
order under the Federal Food, Drug, and
Cosmetic Act (FD&C Act) debarring Yuri
Izurieta for a period of 20 years from
importing articles of food or offering
such articles for importation into the
United States. FDA bases this order on
a finding that Mr. Izurieta was convicted
of six felony counts under Federal law
for conduct relating to the importation
into the United States of an article of
food. Mr. Izurieta was given notice of
the proposed debarment and an
opportunity to request a hearing within
the timeframe prescribed by regulation.
As of November 10, 2011 (30 days after
receipt of the notice), Mr. Izurieta had
not responded. Mr. Izurieta’s failure to
respond constitutes a waiver of his right
to a hearing concerning this action.
DATES: This order is effective January
25, 2012.
ADDRESSES: Submit applications for
termination of debarment to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Kenny Shade, Division of Compliance
Policy (HFC–230), Food and Drug
Administration, 12420 Parklawn Dr.,
Rockville, MD 20857, (301) 796–4640.
SUPPLEMENTARY INFORMATION:
SUMMARY:
srobinson on DSK4SPTVN1PROD with NOTICES
I. Background
Section 306(b)(1)(C) of the FD&C Act
(21 U.S.C. 335a(b)(1)(C)) permits FDA to
debar an individual from importing an
article of food or offering such an article
for import into the United States if FDA
finds, as required by Section
306(b)(3)(A) of the FD&C Act (21 U.S.C.
335a(b)(3)(A)), that the individual has
been convicted of a felony for conduct
relating to the importation into the
United States of any food.
On May 11, 2011, in the United States
District Court for the Southern District
of Florida, Mr. Izureita was convicted of
one count of conspiracy to smuggle
goods into the United States, in
violation of 18 U.S.C. 371, and five
counts of smuggling goods into the
United States, in violation of 18 U.S.C.
VerDate Mar<15>2010
18:09 Jan 24, 2012
Jkt 226001
545. The United States District Court for
the Southern District of Florida entered
judgment against Mr. Izurieta on July
29, 2011.
FDA’s finding that debarment is
appropriate is based on the felony
conviction’s referenced herein for
conduct relating to the importation into
the United States of any food. The
factual basis for these convictions is as
follows: As alleged in the indictment
that was filed against Mr. Izurieta,
beginning on or about April 18, 2007,
and continuing through about December
23, 2010, in violation of 18 U.S.C. 371,
Mr. Izurieta knowingly, and with the
intent to further the object of the
conspiracy, conspired with others to
commit an offense against the United
States—to fraudulently and knowingly
import and bring into the United States
merchandise contrary to law, in
violation of 18 U.S.C. 545. Specifically,
Mr. Izurieta conspired to distribute and
sell imported dairy products that FDA
had detained after receiving notice from
FDA that the dairy products were
suspected to be adulterated.
Mr. Izurieta worked at Naver Trading
Corp., a registered Florida corporation
engaged in the business of importing
and distributing food, including dairy
products, in local and interstate
commerce. While working there, Mr.
Izurieta caused dairy products and other
food to be imported from Honduras and
Nicaragua. Despite requests from FDA,
Mr. Izurieta failed to disclose the
location of shipments of dairy products
after learning that FDA had slated
specific shipments for examination due
to concerns of adulteration with
Escherichia coli, Staphylococcus
aureus, and Salmonella. Mr. Izurieta
also distributed shipments of dairy
products after learning that FDA had
slated specific shipments for
examination due to concerns of
adulteration with E. coli, S. aureus, and
Salmonella. Mr. Izurieta failed to
redeliver for destruction and
exportation shipments of dairy products
that FDA had determined to be
adulterated with E. coli, S. aureus, and
Salmonella, and that were not
authorized for entry into the United
States. Mr. Izurieta then imported and
distributed dairy products that were
adulterated and not authorized for entry
into the United States. This conduct was
in violation of 18 U.S.C. 545.
From approximately April 18, 2007,
and continuing to approximately
December 7, 2010, Mr. Izurieta
fraudulently and knowingly imported
and brought into the United States
merchandise contrary to law. Further,
Mr. Izurieta failed to redeliver, export,
and destroy with FDA supervision the
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
dairy products and other food products
contained in these shipments after
receiving notice from FDA regarding
concerns about the adulteration of these
products with E. coli, S. aureus, and/or
Salmonella.
As a result of his conviction, on
September 28, 2011, FDA sent Mr.
Izurieta a notice by certified mail
proposing to debar him for a period of
20 years from importing articles of food
or offering such articles for import into
the United States. The proposal was
based on a finding under section
306(b)(1)(C) of the FD&C Act that Mr.
Izurieta was convicted of six felony
counts under Federal law for conduct
relating to the importation into the
United States of an article of food
because he conspired to commit
offenses related to the importation of
dairy products into the United States
and imported and brought into the
United States merchandise contrary to
law. It was also based on a
determination, after consideration of the
factors set forth in section 306(c)(3) of
the FD&C Act (21 U.S.C. 335a(c)(3)) that
Mr. Izurieta should be subject to a 20year period of debarment. The proposal
also offered Mr. Izurieta an opportunity
to request a hearing, providing him 30
days from the date of receipt of the letter
in which to file the request, and advised
him that failure to request a hearing
constituted a waiver of the opportunity
for a hearing and of any contentions
concerning this action. Mr. Izurieta
failed to respond within the timeframe
prescribed by regulation and has,
therefore, waived his opportunity for a
hearing and waived any contentions
concerning his debarment (21 CFR part
12).
II. Findings and Order
Therefore, the Director, Office of
Enforcement, Office of Regulatory
Affairs, under section 306(b)(1)(C) of the
FD&C Act, and under authority
delegated to the Director (Staff Manual
Guide 1410.35), finds that Mr. Yuri
Izurieta has been convicted of six felony
counts under Federal law for conduct
relating to the importation of an article
of food into the United States and that
he is subject to 20 years of debarment.
As a result of the foregoing finding,
Mr. Izurieta is debarred for a period of
20 years from importing articles of food
or offering such articles for import into
the United States, effective (see DATES).
Pursuant to section 301(cc) of the FD&C
Act (21 U.S.C. 331(cc)), the importing or
offering for import into the United
States of an article of food by, with the
assistance of, or at the direction of Mr.
Izurieta is a prohibited act.
E:\FR\FM\25JAN1.SGM
25JAN1
Federal Register / Vol. 77, No. 16 / Wednesday, January 25, 2012 / Notices
Any application by Mr. Izurieta for
termination of debarment under section
306(d)(1) (21 U.S.C. 335a(d)(1)) of the
FD&C Act should be identified with
Docket No. FDA–2011–N–0592 and sent
to the Division of Dockets Management
(see ADDRESSES). All such submissions
are to be filed in four copies. The public
availability of information in these
submissions is governed by 21 CFR
10.20(j).
Publicly available submissions may
be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: January 11, 2012.
Armando Zamora,
Acting Director, Office of Enforcement, Office
of Regulatory Affairs.
[FR Doc. 2012–1489 Filed 1–24–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2007–D–0369; (Formerly
Docket No. 2007D–0168)]
Draft and Revised Draft Guidances for
Industry Describing Product-Specific
Bioequivalence Recommendations;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of additional draft and
revised draft product-specific
bioequivalence (BE) recommendations.
The recommendations provide productspecific guidance on the design of BE
studies to support abbreviated new drug
applications (ANDAs). In the Federal
Register of May 31, 2007 (72 FR 30386),
FDA announced the availability of a
draft guidance for industry entitled
‘‘Bioequivalence Recommendations for
Specific Products,’’ explaining the
process that would be used to make
product-specific BE recommendations
available to the public on FDA’s Web
site. The BE recommendations
identified in this notice were developed
using the process described in that
guidance.
srobinson on DSK4SPTVN1PROD with NOTICES
SUMMARY:
Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comments on these draft
and revised draft guidances before it
begins work on the final versions of the
guidances, submit either electronic or
written comments on the draft and
DATES:
VerDate Mar<15>2010
18:09 Jan 24, 2012
Jkt 226001
revised draft product-specific BE
recommendations listed in this notice
by March 26, 2012.
ADDRESSES: Submit written requests for
single copies of the individual BE
guidances to the Division of Drug
Information, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 2201, Silver Spring,
MD 20993–0002. Send one selfaddressed adhesive label to assist that
office in processing your requests. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance recommendations.
Submit electronic comments on the
draft product-specific BE
recommendations to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Doan T. Nguyen, Center for Drug
Evaluation and Research (HFD–600),
Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, (240)
276–8608.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of May 31,
2007, FDA announced the availability of
a draft guidance for industry entitled
‘‘Bioequivalence Recommendations for
Specific Products,’’ which explained the
process that would be used to make
product-specific BE recommendations
available to the public on FDA’s Web
site at https://www.fda.gov/Drugs/
GuidanceCompliance
RegulatoryInformation/Guidances/
default.htm. As described in that draft
guidance, FDA adopted this process as
a means to develop and disseminate
product-specific BE recommendations
and provide a meaningful opportunity
for the public to consider and comment
on those recommendations. Under that
process, draft recommendations are
posted on the FDA’s Web site and
announced periodically in the Federal
Register. The public is encouraged to
submit comments on those
recommendations within 60 days of
their announcement in the Federal
Register. FDA considers any comments
received and either publishes final
recommendations or publishes revised
draft recommendations for comment.
Recommendations were last announced
in the Federal Register of December 1,
2009 (74 FR 62793). This notice
announces draft product-specific
recommendations, either new or
revised, that have been posted on the
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
3777
FDA’s Web site in the period from
December 1, 2009, through June 30,
2011.
II. Drug Products for Which New Draft
Product-Specific BE Recommendations
Are Available
FDA is announcing draft BE productspecific recommendations for drug
products containing the following active
ingredients:
A
Acetaminophen
Acetaminophen; Butalbital (multiple
reference listed drugs (RLDs))
Acetaminophen; Butalbital; Caffeine
(multiple RLDs)
Acetaminophen; Hydrocodone Bitartrate
(multiple RLDs)
Acetaminophen Oxycodone (multiple RLDs)
Acetazolamide
Adapalene
Aliskiren Hemifumarate; Valsartan
Altretamine
Amantadine HCl (multiple RLDs)
Amiodarone HCl
Amitriptyline HCl (multiple RLDs)
Amlodipine Besylate; Telmisartan
Amlodipine; Hydrochlorothiazide; Valsartan
Amoxicillin; Clavulanate Potassium
(multiple RLDs)
Aripiprazole
Aspirin; Butalbital; Caffeine (multiple RLDs)
Aspirin; Dipyridamole
Aspirin; Oxycodone
Aspirin; Butalbital; Caffeine; Codeine
Phosphate
Atovaquone
Auranofin
Azelaic Acid (multiple RLDs)
B
Baclofen (multiple RLDs)
Benazepril HCl
Benzoyl Peroxide Clindamycin Phosphate
(multiple RLDs)
Benzoyl Peroxide; Erythromycin (multiple
RLDs)
Betamethasone Acetate; Sodium Phosphate
Betamethasone Dipropionate; Calcipotriene
Hydrate (multiple RLDs)
Betamethasone Dipropionate; Clotrimazole
Betamethasone; Clotrimazole
Bexarotene
Bosentan
Buprenorphine HCl
Buprenorphine HCl; Naloxone HCl
Bupropion HBr
Bupropion HCl
Buspirone
Butoconazole Nitrate (multiple RLDs)
C
Calcipotriene (multiple RLDs)
Carbidopa; Levodopa
Carisoprodol
Carvedilol Phosphate
Cefaclor
Cefadroxil; Cefadroxil Hemihydrate
Cefditoren Pivoxil
Cefixime
Cefuroxime Axetil (multiple RLDs)
Cetirizine HCl
Chlorambucil
Chlorpheniramine Polistirex; Hydrocodone
Polistirex
E:\FR\FM\25JAN1.SGM
25JAN1
Agencies
[Federal Register Volume 77, Number 16 (Wednesday, January 25, 2012)]
[Notices]
[Pages 3776-3777]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1489]
[[Page 3776]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0592]
Yuri Izurieta: Debarment Order
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Food and Drug Administration (FDA) is issuing an
order under the Federal Food, Drug, and Cosmetic Act (FD&C Act)
debarring Yuri Izurieta for a period of 20 years from importing
articles of food or offering such articles for importation into the
United States. FDA bases this order on a finding that Mr. Izurieta was
convicted of six felony counts under Federal law for conduct relating
to the importation into the United States of an article of food. Mr.
Izurieta was given notice of the proposed debarment and an opportunity
to request a hearing within the timeframe prescribed by regulation. As
of November 10, 2011 (30 days after receipt of the notice), Mr.
Izurieta had not responded. Mr. Izurieta's failure to respond
constitutes a waiver of his right to a hearing concerning this action.
DATES: This order is effective January 25, 2012.
ADDRESSES: Submit applications for termination of debarment to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kenny Shade, Division of Compliance
Policy (HFC-230), Food and Drug Administration, 12420 Parklawn Dr.,
Rockville, MD 20857, (301) 796-4640.
SUPPLEMENTARY INFORMATION:
I. Background
Section 306(b)(1)(C) of the FD&C Act (21 U.S.C. 335a(b)(1)(C))
permits FDA to debar an individual from importing an article of food or
offering such an article for import into the United States if FDA
finds, as required by Section 306(b)(3)(A) of the FD&C Act (21 U.S.C.
335a(b)(3)(A)), that the individual has been convicted of a felony for
conduct relating to the importation into the United States of any food.
On May 11, 2011, in the United States District Court for the
Southern District of Florida, Mr. Izureita was convicted of one count
of conspiracy to smuggle goods into the United States, in violation of
18 U.S.C. 371, and five counts of smuggling goods into the United
States, in violation of 18 U.S.C. 545. The United States District Court
for the Southern District of Florida entered judgment against Mr.
Izurieta on July 29, 2011.
FDA's finding that debarment is appropriate is based on the felony
conviction's referenced herein for conduct relating to the importation
into the United States of any food. The factual basis for these
convictions is as follows: As alleged in the indictment that was filed
against Mr. Izurieta, beginning on or about April 18, 2007, and
continuing through about December 23, 2010, in violation of 18 U.S.C.
371, Mr. Izurieta knowingly, and with the intent to further the object
of the conspiracy, conspired with others to commit an offense against
the United States--to fraudulently and knowingly import and bring into
the United States merchandise contrary to law, in violation of 18
U.S.C. 545. Specifically, Mr. Izurieta conspired to distribute and sell
imported dairy products that FDA had detained after receiving notice
from FDA that the dairy products were suspected to be adulterated.
Mr. Izurieta worked at Naver Trading Corp., a registered Florida
corporation engaged in the business of importing and distributing food,
including dairy products, in local and interstate commerce. While
working there, Mr. Izurieta caused dairy products and other food to be
imported from Honduras and Nicaragua. Despite requests from FDA, Mr.
Izurieta failed to disclose the location of shipments of dairy products
after learning that FDA had slated specific shipments for examination
due to concerns of adulteration with Escherichia coli, Staphylococcus
aureus, and Salmonella. Mr. Izurieta also distributed shipments of
dairy products after learning that FDA had slated specific shipments
for examination due to concerns of adulteration with E. coli, S.
aureus, and Salmonella. Mr. Izurieta failed to redeliver for
destruction and exportation shipments of dairy products that FDA had
determined to be adulterated with E. coli, S. aureus, and Salmonella,
and that were not authorized for entry into the United States. Mr.
Izurieta then imported and distributed dairy products that were
adulterated and not authorized for entry into the United States. This
conduct was in violation of 18 U.S.C. 545.
From approximately April 18, 2007, and continuing to approximately
December 7, 2010, Mr. Izurieta fraudulently and knowingly imported and
brought into the United States merchandise contrary to law. Further,
Mr. Izurieta failed to redeliver, export, and destroy with FDA
supervision the dairy products and other food products contained in
these shipments after receiving notice from FDA regarding concerns
about the adulteration of these products with E. coli, S. aureus, and/
or Salmonella.
As a result of his conviction, on September 28, 2011, FDA sent Mr.
Izurieta a notice by certified mail proposing to debar him for a period
of 20 years from importing articles of food or offering such articles
for import into the United States. The proposal was based on a finding
under section 306(b)(1)(C) of the FD&C Act that Mr. Izurieta was
convicted of six felony counts under Federal law for conduct relating
to the importation into the United States of an article of food because
he conspired to commit offenses related to the importation of dairy
products into the United States and imported and brought into the
United States merchandise contrary to law. It was also based on a
determination, after consideration of the factors set forth in section
306(c)(3) of the FD&C Act (21 U.S.C. 335a(c)(3)) that Mr. Izurieta
should be subject to a 20-year period of debarment. The proposal also
offered Mr. Izurieta an opportunity to request a hearing, providing him
30 days from the date of receipt of the letter in which to file the
request, and advised him that failure to request a hearing constituted
a waiver of the opportunity for a hearing and of any contentions
concerning this action. Mr. Izurieta failed to respond within the
timeframe prescribed by regulation and has, therefore, waived his
opportunity for a hearing and waived any contentions concerning his
debarment (21 CFR part 12).
II. Findings and Order
Therefore, the Director, Office of Enforcement, Office of
Regulatory Affairs, under section 306(b)(1)(C) of the FD&C Act, and
under authority delegated to the Director (Staff Manual Guide 1410.35),
finds that Mr. Yuri Izurieta has been convicted of six felony counts
under Federal law for conduct relating to the importation of an article
of food into the United States and that he is subject to 20 years of
debarment.
As a result of the foregoing finding, Mr. Izurieta is debarred for
a period of 20 years from importing articles of food or offering such
articles for import into the United States, effective (see DATES).
Pursuant to section 301(cc) of the FD&C Act (21 U.S.C. 331(cc)), the
importing or offering for import into the United States of an article
of food by, with the assistance of, or at the direction of Mr. Izurieta
is a prohibited act.
[[Page 3777]]
Any application by Mr. Izurieta for termination of debarment under
section 306(d)(1) (21 U.S.C. 335a(d)(1)) of the FD&C Act should be
identified with Docket No. FDA-2011-N-0592 and sent to the Division of
Dockets Management (see ADDRESSES). All such submissions are to be
filed in four copies. The public availability of information in these
submissions is governed by 21 CFR 10.20(j).
Publicly available submissions may be seen in the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
Dated: January 11, 2012.
Armando Zamora,
Acting Director, Office of Enforcement, Office of Regulatory Affairs.
[FR Doc. 2012-1489 Filed 1-24-12; 8:45 am]
BILLING CODE 4160-01-P